Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Roggenbuck

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Plos One|June 6, 2015
Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac DiseaseMartin W Laass, Nadja Röber, Ursula Range, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2012
A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiencyKarsten Conrad, Dirk Roggenbuck, Annelore Ittenson, et al.
Turkish Journal of Biology = Turk Biyoloji Dergisi|December 29, 2023
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancerBilge Debeleç Bütüner, Nurşah Ertunç Hasbal, Elif Işel, et al.
Advances in Clinical Chemistry|June 4, 2013
Glycoprotein 2 antibodies in Crohn's diseaseDirk Roggenbuck, Dirk Reinhold, Lael Werner, et al.
World Journal of Gastroenterology|December 11, 2023
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodiesNora Sipeki, Patricia Julianna Kovats, Claudia Deutschmann, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2013
Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challengesDirk Roggenbuck, Dirk Reinhold, Peter Schierack, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2020
Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosisManuel Comabella, Claudia Deutschmann, Luciana Midaglia, et al.
European Radiology Experimental|November 29, 2018
The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytesBjörn Friebe, Frank Godenschweger, Mahsa Fatahi, et al.
Clinical Laboratory|May 31, 2008
Are porcine and human TSH receptor antibody measurements comparable?Klaus Zöphel, Philipp von Landenberg, Dirk Roggenbuck, et al.
Radiology|October 1, 2016
Impact of in Vivo High-Field-Strength and Ultra-High-Field-Strength MR Imaging on DNA Double-Strand-Break Formation in Human LymphocytesAnnika Reddig, Mahsa Fatahi, Dirk Roggenbuck, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Plos One|June 6, 2015
Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac DiseaseMartin W Laass, Nadja Röber, Ursula Range, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2012
A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiencyKarsten Conrad, Dirk Roggenbuck, Annelore Ittenson, et al.
Turkish Journal of Biology = Turk Biyoloji Dergisi|December 29, 2023
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancerBilge Debeleç Bütüner, Nurşah Ertunç Hasbal, Elif Işel, et al.
Advances in Clinical Chemistry|June 4, 2013
Glycoprotein 2 antibodies in Crohn's diseaseDirk Roggenbuck, Dirk Reinhold, Lael Werner, et al.
World Journal of Gastroenterology|December 11, 2023
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodiesNora Sipeki, Patricia Julianna Kovats, Claudia Deutschmann, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2013
Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challengesDirk Roggenbuck, Dirk Reinhold, Peter Schierack, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2020
Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosisManuel Comabella, Claudia Deutschmann, Luciana Midaglia, et al.
European Radiology Experimental|November 29, 2018
The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytesBjörn Friebe, Frank Godenschweger, Mahsa Fatahi, et al.
Clinical Laboratory|May 31, 2008
Are porcine and human TSH receptor antibody measurements comparable?Klaus Zöphel, Philipp von Landenberg, Dirk Roggenbuck, et al.
Radiology|October 1, 2016
Impact of in Vivo High-Field-Strength and Ultra-High-Field-Strength MR Imaging on DNA Double-Strand-Break Formation in Human LymphocytesAnnika Reddig, Mahsa Fatahi, Dirk Roggenbuck, et al.
Pageof 15